Bincy Kappen, APRN
Nurse Practitioner · Oklahoma City, OKNPI 1477222347
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 238 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $2,031 and has fallen 66.5% since, to $681 in 2025. Among nurse practitioner clinicians in OK with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 238 payments — averaging $19.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Fresenius USA Marketing, Inc.$925
- AstraZeneca$733
- Amgen$730
- Travere Therapeutics, Inc.$383
- Aurinia Pharma U.S., Inc.$358
- Novo Nordisk$291
- plus $1K from 18 others
What the payments were for
- Food & beverage$4,743100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Fresenius USA Marketing, Inc. | 72 | $925 |
| AstraZeneca(2 entities) | 22 | $733 |
| Amgen(2 entities) | 31 | $730 |
| Travere Therapeutics, Inc. | 14 | $383 |
| Aurinia Pharma U.S., Inc. | 14 | $358 |
| Novo Nordisk | 16 | $291 |
| Bayer | 20 | $274 |
| OPKO Pharmaceuticals, LLC | 7 | $119 |
| Boehringer Ingelheim | 7 | $116 |
| ANI Pharmaceuticals, Inc. | 5 | $113 |
| Mallinckrodt Hospital Products Inc. | 4 | $101 |
| Ardelyx, Inc. | 5 | $88 |
| Vifor Pharma, Inc. | 4 | $84 |
| Nxstage Medical, Inc. | 1 | $81 |
| Pharmacosmos Therapeutics Inc. | 3 | $53 |
| Shield Therapeutics Inc | 1 | $51 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Calliditas Therapeutics US Inc. | 2 | $40 |
| GSK | 2 | $37 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,743 in reported general payments places this provider in the 90th percentile of 824 nurse practitioner providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sevelamer Carbonate | 12 | $6,808 |
| Furosemide | 22 | $66 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Oklahoma City
- Sara GoreOklahoma City$52K
- Russell RoomsOklahoma City$24K
- Grant YoungOklahoma City$15K
- Janelle WagnerOklahoma City$13K
- Stefanie RollinsOklahoma City$13K
- Lacey CampbellOklahoma City$13K
- Stacey Waggoner FisherOklahoma City$9K
- Karie StewartOklahoma City$9K
- Lori CraigOklahoma City$8K
- Jennifer LewisOklahoma City$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.